To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene YAP1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
457 supporting clones for gene YAP1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
NM_001130145.1   .a 1 to 5368 1 to 5368 exact RefSeq, AAA   5368/5368
(100 %)
0 diff
(100 %id)
BC038235 Pancreas, Spleen, adult pooled .a 78 to 2398 1 to 2321 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) 2321/2321
(100 %)
0 diff
(100 %id)
BX456919 thymus .a 369 to 1355 1 to 979       979/979
(100 %)
17 diff
(98.3 %id)
CN333193 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 707 to 1436 1 to 730       730/730
(100 %)
5 diff
(99.4 %id)
AA433865 ovarian tumor, ovary .a 713 to 1237 1 to 524       524/524
(100 %)
2 diff
(99.7 %id)
EC537480 Prostate .a 799 to 887 1 to 89       89/89
(100 %)
3 diff
(96.7 %id)
EC449481 Prostate .a 800 to 887 1 to 87       87/87
(100 %)
3 diff
(96.6 %id)
EC491395 Prostate .a 806 to 887 9 to 89       81/89
(91 %)
1 diff
(98.9 %id)
AA508423 Prostate .a 933 to 1213 1 to 281       281/281
(100 %)
0 diff
(100 %id)
BF691723 melanotic melanoma, high MDR, skin .a 1276 to 2032 1 to 759       759/809
(93 %)
18 diff
(97.8 %id)
BE770591 prostate_tumor .a 1331 to 1589 267 to 10       258/267
(96 %)
2 diff
(99.3 %id)
BE888302 leiomyosarcoma, uterus .a 1396 to 2113 1 to 717   available from MGC,   717/1045
(68 %)
18 diff
(98.3 %id)
BF808022 colon_ins .a 1401 to 1899 18 to 516       499/516
(96 %)
7 diff
(98.7 %id)
BC026212 Uterus, leiomyosarcoma .a 1402 to 4681 1 to 3277   tiling clone, available from MGC, AAA   3277/3277
(100 %)
3 diff
(100.0 %id)
BE169381 head_neck .a 1420 to 2028 17 to 624       608/624
(97 %)
8 diff
(98.8 %id)
BF995040 placenta_normal .a 1428 to 1840 472 to 59       414/472
(87 %)
1 diff
(99.8 %id)
BF995185 placenta_normal .a 1428 to 1840 472 to 59       414/472
(87 %)
1 diff
(99.8 %id)
BQ225173 leiomyosarcoma, uterus .a 1453 to 2093 1 to 648       648/1070
(60 %)
10 diff
(99.1 %id)
BE717562 head_neck .a 1461 to 1758 307 to 12       296/309
(95 %)
4 diff
(98.8 %id)
BE829945 lung_tumor .a 1461 to 1945 494 to 10       485/496
(97 %)
3 diff
(99.4 %id)
BE837005 prostate_normal .a 1461 to 1752 312 to 21       292/314
(92 %)
5 diff
(98.5 %id)
BE837010 prostate_normal .a 1461 to 1698 22 to 259       238/272
(87 %)
11 diff
(96.0 %id)
BE717597 head_neck .a 1473 to 1752 1 to 280       280/287
(97 %)
7 diff
(97.6 %id)
AL566433 brain, fetal brain .a 1556 to 2537 979 to 1       979/992
(98 %)
12 diff
(98.8 %id)
BF840919 head_neck .a 1569 to 1888 11 to 335       325/335
(97 %)
11 diff
(96.8 %id)
AI669397 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 1574 to 2126 555 to 2       554/555
(99 %)
7 diff
(98.8 %id)
AL701889 human skeletal muscle .a 1576 to 2011 1 to 436       436/436
(100 %)
1 diff
(99.8 %id)
AL701115 human skeletal muscle .a 1577 to 2155 1 to 579       579/579
(100 %)
1 diff
(99.9 %id)
AL700637 human skeletal muscle .a 1590 to 2171 1 to 582       582/582
(100 %)
3 diff
(99.5 %id)
CN333195 embryonic stem cells, DMSO-treated H9 cellline .a 1594 to 2016 1 to 423       423/456
(92 %)
9 diff
(98.1 %id)
BX459258 placenta .a 1644 to 2657 1 to 1014       1014/1015
(99 %)
7 diff
(99.4 %id)
AW021199 cochlea, ear .a 1645 to 2132 14 to 500       487/500
(97 %)
6 diff
(98.8 %id)
TI_154122726   .a 1654 to 2566 1003 to 105   AAA   899/983
(91 %)
29 diff
(97.1 %id)
BG620755 placenta .a 1655 to 2368 1 to 714       714/717
(99 %)
9 diff
(98.8 %id)
AI189637 placenta .a 1679 to 1880 202 to 1       202/202
(100 %)
12 diff
(94.1 %id)
TI_149308176   .a 1714 to 2547 915 to 87   AAA Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) 829/972
(85 %)
15 diff
(98.5 %id)
TI_154110534   .a 1714 to 2566 934 to 99   AAA   836/931
(89 %)
19 diff
(98.0 %id)
AL700047 human skeletal muscle .a 1716 to 2412 1 to 700       700/700
(100 %)
3 diff
(99.6 %id)
CB250608 Human Lung Epithelial cells, lung .a 1744 to 2381 655 to 19   AAA Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) 637/646
(98 %)
1 diff
(99.9 %id)
DA248769 brain .a 1746 to 2326 2 to 583   capped   582/582
(100 %)
2 diff
(99.7 %id)
BM023567 Islets of Langerhans, Pancreas .a 1748 to 2252 1 to 505   fully sequenced, Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) 505/505
(100 %)
6 diff
(98.9 %id)
AI159793 placenta .a 1757 to 2251 499 to 5       495/499
(99 %)
0 diff
(100 %id)
BM023573 Islets of Langerhans, Pancreas .a 1764 to 2268 1 to 505   fully sequenced,   505/505
(100 %)
3 diff
(99.5 %id)
CA426862 cell lines, Chondrosarcoma .a 1802 to 2564 778 to 19   AAA   760/761
(99 %)
4 diff
(99.5 %id)
BQ008172 Chondrosarcoma, Left Pubic Bone .a 1821 to 2547 743 to 19   AAA Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) 725/725
(100 %)
3 diff
(99.6 %id)
CX165164 human embryonic stem cells differentiated toan early endodermal cell type .a 1849 to 2629 1 to 781       781/781
(100 %)
1 diff
(99.9 %id)
CA432224 cell lines, Enchondroma .a 1854 to 2566 730 to 19   AAA   712/712
(100 %)
3 diff
(99.6 %id)
BI492141 cochlea, ear .a 1897 to 2557 661 to 1       661/661
(100 %)
0 diff
(100 %id)
DB291045 uterus .a 1901 to 2469 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
BU687045 lung, Primary Lung Epithelial Cells .a 1926 to 2547 640 to 19   AAA Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) 622/622
(100 %)
1 diff
(99.9 %id)
CN479972 Chondrosarcoma, Left Pubic Bone .a 1926 to 2566 657 to 17   AAA   641/641
(100 %)
0 diff
(100 %id)
N87724   .a 1943 to 2239 1 to 295       295/295
(100 %)
6 diff
(98.0 %id)
EH331015   .a 1965 to 2021 1 to 57       57/57
(100 %)
2 diff
(96.5 %id)
CN333187 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1969 to 2613 37 to 681       645/681
(94 %)
6 diff
(99.2 %id)
CV573879 cornea, eye .a 1997 to 2602 1 to 606       606/606
(100 %)
0 diff
(100 %id)
AI745185 pooled .a 2005 to 2568 564 to 1       564/564
(100 %)
1 diff
(99.9 %id)
AI080391 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 2031 to 2541 516 to 6       511/516
(99 %)
0 diff
(100 %id)
CN333188 embryonic stem cells, cell lines H1, H7, andH9 .a 2046 to 2652 1 to 606       606/606
(100 %)
5 diff
(99.2 %id)
BF028394 bladder, carcinoma, cell line .a 2061 to 2562 1 to 497   AAA   497/497
(100 %)
11 diff
(97.8 %id)
AA708798 uterus .a 2075 to 2541 472 to 6       467/472
(98 %)
0 diff
(100 %id)
BE888994 leiomyosarcoma, uterus .a 2082 to 2566 1 to 479   AAA   479/479
(100 %)
6 diff
(98.8 %id)
AW081855 esophagus, squamous cell carcinoma .a 2086 to 2497 412 to 1       412/412
(100 %)
0 diff
(100 %id)
DB274695 uterus .a 2099 to 2619 2 to 523   capped   522/522
(100 %)
2 diff
(99.7 %id)
AI453014 pooled .a 2121 to 2566 456 to 11   AAA   446/446
(100 %)
1 diff
(99.8 %id)
AW117329 pooled .a 2125 to 2571 445 to 1       445/445
(100 %)
6 diff
(98.7 %id)
AA757558 pineal gland .a 2129 to 2559 436 to 1       436/441
(98 %)
19 diff
(95.7 %id)
BF379904 uterus_tumor .a 2135 to 2471 6 to 342       337/342
(98 %)
8 diff
(97.7 %id)
AI224863 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 2137 to 2541 410 to 6       405/410
(98 %)
0 diff
(100 %id)
AW129441 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 2141 to 2566 453 to 28   AAA   426/426
(100 %)
5 diff
(98.9 %id)
BF094360 uterus_tumor .a 2148 to 2456 31 to 339       309/339
(91 %)
6 diff
(98.3 %id)
AI911652 adenocarcinoma, Pancreas .a 2154 to 2497 344 to 1       344/344
(100 %)
0 diff
(100 %id)
AI590105 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 2167 to 2497 331 to 1       331/331
(100 %)
0 diff
(100 %id)
AA948114 adenocarcinoma, colon .a 2176 to 2566 391 to 1       391/391
(100 %)
0 diff
(100 %id)
AI346143 adenocarcinoma, colon .a 2177 to 2566 390 to 1       390/390
(100 %)
0 diff
(100 %id)
AI281049 adenocarcinoma, colon .a 2187 to 2566 380 to 1       380/380
(100 %)
0 diff
(100 %id)
CN333201 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 2200 to 2599 19 to 422       404/422
(95 %)
6 diff
(98.6 %id)
BM023272 Islets of Langerhans, Pancreas .a 2222 to 2555 344 to 11   fully sequenced, AAA Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) 334/334
(100 %)
5 diff
(98.6 %id)
AI381643 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 2234 to 2548 315 to 1       315/315
(100 %)
1 diff
(99.7 %id)
BQ023069 placenta .a 2234 to 2564 352 to 22       331/352
(94 %)
0 diff
(100 %id)
AI264814 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 2236 to 2541 311 to 6       306/311
(98 %)
0 diff
(100 %id)
BM023278 Islets of Langerhans, Pancreas .a 2238 to 2556 328 to 10   fully sequenced,   319/328
(97 %)
8 diff
(97.6 %id)
BG289477 bladder, transitional cell papilloma, cell line .a 2255 to 2902 1 to 641       641/926
(69 %)
26 diff
(97.2 %id)
BF832905 head_neck .a 2284 to 2502 1 to 218       218/218
(100 %)
6 diff
(97.3 %id)
BF832942 head_neck .a 2292 to 2465 8 to 181       174/182
(95 %)
6 diff
(96.8 %id)
CX788543 human embryonic stem cells .a 2312 to 2662 1 to 352       352/352
(100 %)
2 diff
(99.5 %id)
CN333203 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 2323 to 2656 1 to 336       336/336
(100 %)
4 diff
(98.9 %id)
DA574082   .a 2326 to 2882 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
AI521478 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 2360 to 2497 138 to 1       138/138
(100 %)
1 diff
(99.3 %id)
BE927597 colon .a 2400 to 2517 1 to 118       118/133
(88 %)
11 diff
(91.8 %id)
BP336443 coronary artery .a 2437 to 2906 1 to 470       470/582
(80 %)
17 diff
(97.1 %id)
DA556196   .a 2446 to 3003 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
CU443781 epidermis .a 2452 to 3009 10 to 567       558/567
(98 %)
6 diff
(99.0 %id)
CU444998 epidermis .a 2452 to 2807 10 to 365       356/365
(97 %)
12 diff
(96.8 %id)
CU449382 epidermis .a 2452 to 2861 10 to 419       410/419
(97 %)
6 diff
(98.6 %id)
CU451137 epidermis .a 2452 to 3067 10 to 625       616/625
(98 %)
6 diff
(99.1 %id)
CU455121 epidermis .a 2452 to 2972 10 to 530       521/532
(97 %)
2 diff
(99.7 %id)
CU456289 epidermis .a 2452 to 2984 10 to 543       534/545
(97 %)
4 diff
(99.3 %id)
DA499067 brain .a 2482 to 3028 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
DA376438 thalamus .a 2504 to 3042 2 to 540   capped   539/539
(100 %)
1 diff
(99.9 %id)
DA717155   .a 2510 to 2850 165 to 505   capped   341/504
(67 %)
6 diff
(98.9 %id)
EH329735   .a 2555 to 2672 1 to 118       118/118
(100 %)
0 diff
(100 %id)
DA371243 thalamus .a 2689 to 3240 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
CB051690 leiomyosarcoma, soft tissue .a 2695 to 3234 1 to 540       540/540
(100 %)
22 diff
(96.0 %id)
AW995395 breast_normal .a 2762 to 3256 18 to 511       494/511
(96 %)
6 diff
(98.9 %id)
DA150250 amygdala .a 2780 to 3351 2 to 573   capped   572/572
(100 %)
2 diff
(99.7 %id)
DA166412 amygdala .a 2780 to 3344 2 to 567   capped   566/566
(100 %)
3 diff
(99.5 %id)
AW837804 leiomios .a 2790 to 2984 18 to 211       194/211
(91 %)
6 diff
(97.2 %id)
BP275346 Kidney .a 2793 to 3370 1 to 577       577/583
(98 %)
2 diff
(99.7 %id)
CN401258 embryonic stem cells, DMSO-treated H9 cellline .a 2794 to 3362 1 to 569       569/569
(100 %)
6 diff
(99.0 %id)
DA551124   .a 2795 to 3257 2 to 467   capped   466/466
(100 %)
4 diff
(99.2 %id)
DA597631   .a 2837 to 3392 2 to 557   capped   556/556
(100 %)
2 diff
(99.7 %id)
DA832795 placenta .a 2867 to 3614 2 to 754   capped   753/754
(99 %)
12 diff
(98.5 %id)
BP238270 Liver .a 2871 to 3479 1 to 609       609/609
(100 %)
2 diff
(99.7 %id)
BP291819 lung .a 2878 to 3457 1 to 582       582/582
(100 %)
4 diff
(99.4 %id)
DB263381 uterus .a 2944 to 3524 2 to 582   capped   581/581
(100 %)
3 diff
(99.5 %id)
DA392150 thalamus .a 2948 to 3526 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
DA345505 substantia nigra .a 2952 to 3523 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
DA887593   .a 2964 to 3515 2 to 554   capped   553/553
(100 %)
3 diff
(99.5 %id)
BQ880612 dorsal root ganglia .a 2992 to 3896 1 to 910   tiling clone,   910/942
(96 %)
9 diff
(99.1 %id)
BQ431773 leiomyosarcoma, uterus .a 3031 to 3873 12 to 854       843/855
(98 %)
5 diff
(99.5 %id)
AL601088   .a 3052 to 3386 1 to 335       335/335
(100 %)
2 diff
(99.5 %id)
BG288267 bladder, transitional cell papilloma, cell line .a 3056 to 3833 1 to 760       760/904
(84 %)
36 diff
(96.1 %id)
BP237635 Liver .a 3077 to 3677 1 to 602       602/602
(100 %)
9 diff
(98.6 %id)
BI091233 cervix .a 3102 to 3958 1 to 849       849/864
(98 %)
29 diff
(96.7 %id)
W20259 parathyroid gland, parathyroid tumor .a 3145 to 3349 1 to 207       207/207
(100 %)
3 diff
(98.6 %id)
AW754187 colon .a 3154 to 3765 1 to 610       610/610
(100 %)
15 diff
(97.6 %id)
AW754196 colon .a 3162 to 3469 308 to 2       307/310
(99 %)
0 diff
(100 %id)
BG287486 bladder, transitional cell papilloma, cell line .a 3169 to 3786 1 to 625       625/708
(88 %)
26 diff
(96.4 %id)
BG289493 bladder, transitional cell papilloma, cell line .a 3171 to 3814 1 to 633       633/943
(67 %)
17 diff
(98.2 %id)
BF366473 nervous_tumor .a 3172 to 3526 1 to 355       355/355
(100 %)
1 diff
(99.8 %id)
BP279647   .a 3211 to 3792 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BP239840 Liver .a 3244 to 3859 1 to 615       615/617
(99 %)
21 diff
(96.6 %id)
AA182461   .a 3252 to 3613 1 to 362       362/362
(100 %)
0 diff
(100 %id)
DA978971 synovial membrane tissue from rheumatioidarthritis .a 3270 to 3821 2 to 554   capped   553/553
(100 %)
2 diff
(99.7 %id)
CN401257 embryonic stem cells, DMSO-treated H9 cellline .a 3294 to 3865 1 to 573       573/573
(100 %)
6 diff
(99.0 %id)
BI256771 cervical carcinoma cell line, cervix .a 3385 to 4116 1 to 729       729/729
(100 %)
6 diff
(99.2 %id)
BP260366 heart .a 3431 to 3982 1 to 552       552/552
(100 %)
0 diff
(100 %id)
AA345313 gall bladder .a 3433 to 3655 1 to 225       225/225
(100 %)
2 diff
(99.2 %id)
BG289616 bladder, transitional cell papilloma, cell line .a 3434 to 4077 1 to 648       648/913
(70 %)
10 diff
(99.0 %id)
DA892907 skeletal muscle .a 3449 to 4230 2 to 784   capped   783/790
(99 %)
4 diff
(99.5 %id)
CN401261 embryonic stem cells, DMSO-treated H9 cellline .a 3504 to 4218 1 to 715       715/718
(99 %)
5 diff
(99.4 %id)
AW754186 colon .a 3507 to 4090 584 to 1       584/584
(100 %)
9 diff
(98.5 %id)
AA091179   .a 3533 to 3715 1 to 177       177/179
(98 %)
10 diff
(94.5 %id)
BU145860 dorsal root ganglia .a 3536 to 4224 1 to 691       691/951
(72 %)
18 diff
(98.2 %id)
CN401253 embryonic stem cells, DMSO-treated H9 cellline .a 3557 to 4202 7 to 654       648/654
(99 %)
6 diff
(99.1 %id)
AW754183 colon .a 3564 to 4101 550 to 1       550/612
(89 %)
38 diff
(93.8 %id)
CX783498 human embryonic stem cells .a 3585 to 4233 12 to 659       648/660
(98 %)
2 diff
(99.7 %id)
N36721 melanocyte .a 3586 to 4093 1 to 514       514/514
(100 %)
7 diff
(98.7 %id)
AA186831   .a 3609 to 3964 1 to 363       363/442
(82 %)
11 diff
(97.6 %id)
BF925482 nervous_tumor .a 3630 to 3983 1 to 353       353/353
(100 %)
10 diff
(97.2 %id)
ES311890 frontal balding hair, skin .a 3658 to 3846 1 to 187       187/187
(100 %)
2 diff
(99.0 %id)
BF379458 uterus_tumor .a 3707 to 4166 71 to 528       458/535
(85 %)
3 diff
(99.5 %id)
BF333576 colon_normal .a 3729 to 4087 385 to 26       360/395
(91 %)
0 diff
(100 %id)
CN401254 embryonic stem cells, DMSO-treated H9 cellline .a 3742 to 4237 1 to 496   tiling clone,   496/496
(100 %)
4 diff
(99.2 %id)
CN401260 embryonic stem cells, DMSO-treated H9 cellline .a 3754 to 4181 1 to 428       428/428
(100 %)
0 diff
(100 %id)
CN401256 embryonic stem cells, cell lines H1, H7, andH9 .a 3764 to 4232 1 to 469       469/469
(100 %)
1 diff
(99.8 %id)
AW754202 colon .a 3772 to 4088 40 to 354       315/356
(88 %)
18 diff
(95.0 %id)
AW861566 colon .a 3772 to 4090 6 to 327       322/327
(98 %)
6 diff
(98.2 %id)
BF753446 colon .a 3795 to 4021 14 to 240       227/242
(93 %)
1 diff
(99.6 %id)
BF753488 colon .a 3801 to 3998 208 to 15     Submitted on the opposite strand 194/208
(93 %)
0 diff
(100 %id)
BF753490 colon .a 3801 to 3960 193 to 37     Submitted on the opposite strand 157/193
(81 %)
0 diff
(100 %id)
BF753534 colon .a 3801 to 4020 219 to 1     Submitted on the opposite strand 219/219
(100 %)
2 diff
(99.1 %id)
BQ894340 dorsal root ganglia .a 3811 to 4239 16 to 443       428/1003
(42 %)
4 diff
(99.7 %id)
CN401252 embryonic stem cells, DMSO-treated H9 cellline .a 3826 to 4104 1 to 279       279/279
(100 %)
5 diff
(98.3 %id)
BM825245 Ascites, stomach .a 3835 to 4225 1 to 391       391/391
(100 %)
0 diff
(100 %id)
DA569469 whole embryo, mainly head .a 3900 to 4240 18 to 358   capped   341/371
(91 %)
6 diff
(98.4 %id)
BP378083 uterus .a 3901 to 4479 1 to 580       580/580
(100 %)
17 diff
(97.1 %id)
BF207476 bladder, carcinoma, cell line .a 3930 to 4595 1 to 674       674/815
(82 %)
86 diff
(89.5 %id)
BF351865 head_neck .a 3939 to 4104 25 to 190       166/190
(87 %)
6 diff
(96.9 %id)
TI_154105145   .a 3976 to 4681 788 to 82   AAA   707/707
(100 %)
1 diff
(99.9 %id)
BF242444 bone marrow, from acute myelogenous leukemia .a 3998 to 4553 1 to 552       552/840
(65 %)
17 diff
(98.0 %id)
AL036707 brain .a 4018 to 4225 1 to 208       208/208
(100 %)
0 diff
(100 %id)
BG506440 lung .a 4026 to 4832 1 to 807       807/880
(91 %)
49 diff
(94.5 %id)
W24622 lung .a 4033 to 4198 237 to 405       370/405
(91 %)
7 diff
(98.3 %id)
BU928382 brain, glioblastoma .a 4035 to 4546 1 to 515       515/885
(58 %)
6 diff
(99.4 %id)
BF212308 bone marrow, from chronic myelogenous leukemia .a 4064 to 4723 1 to 650       650/903
(71 %)
35 diff
(96.2 %id)
BF210166 bone marrow, from chronic myelogenous leukemia .a 4064 to 4625 1 to 568       568/670
(84 %)
40 diff
(94.1 %id)
BF239564 bone marrow, from chronic myelogenous leukemia .a 4064 to 4754 1 to 695       695/739
(94 %)
65 diff
(91.3 %id)
BG171209 hypernephroma, cell line, Kidney .a 4070 to 4689 1 to 618       618/931
(66 %)
15 diff
(98.4 %id)
BF038669 adenocarcinoma, ovary .a 4118 to 4832 1 to 715       715/882
(81 %)
18 diff
(98.0 %id)
AJ708373 heart .a 4212 to 4745 1 to 533   tiling clone,   533/533
(100 %)
1 diff
(99.9 %id)
BF977972 melanotic melanoma, high MDR, skin .a 4227 to 4903 1 to 676       676/680
(99 %)
20 diff
(97.1 %id)
CN333189 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 4240 to 4959 1 to 720       720/720
(100 %)
1 diff
(99.9 %id)
CN333199 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 4240 to 4871 1 to 633       633/633
(100 %)
3 diff
(99.6 %id)
CN333202 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 4240 to 4621 1 to 382       382/386
(98 %)
1 diff
(99.8 %id)
CN333186 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 4242 to 4681 1 to 440       440/440
(100 %)
0 diff
(100 %id)
ES312532 frontal balding hair, skin .a 4242 to 4431 1 to 190       190/190
(100 %)
4 diff
(97.9 %id)
BX089620 melanocyte .a 4244 to 5021 1 to 780       780/780
(100 %)
2 diff
(99.8 %id)
N29276 melanocyte .a 4245 to 4695 1 to 451       451/452
(99 %)
4 diff
(99.2 %id)
N29249 melanocyte .a 4246 to 4721 1 to 479       479/480
(99 %)
8 diff
(98.4 %id)
CB135393 Liver .a 4246 to 4496 1 to 251       251/251
(100 %)
1 diff
(99.7 %id)
CN333184 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 4247 to 4958 9 to 720       712/720
(98 %)
6 diff
(99.2 %id)
BI261054 cervical carcinoma cell line, cervix .a 4247 to 5051 1 to 819       819/825
(99 %)
22 diff
(97.4 %id)
H03714 placenta .a 4248 to 4688 1 to 447       447/447
(100 %)
11 diff
(97.6 %id)
AA557632 breast .a 4248 to 4684 437 to 1       437/446
(97 %)
0 diff
(100 %id)
CN333198 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 4250 to 4913 1 to 665       665/665
(100 %)
3 diff
(99.6 %id)
CN333192 embryonic stem cells, cell lines H1, H7, andH9 .a 4251 to 5066 1 to 816       816/816
(100 %)
1 diff
(99.9 %id)
BF248367 melanotic melanoma, high MDR, skin .a 4253 to 4879 1 to 618       618/618
(100 %)
15 diff
(97.6 %id)
N83579   .a 4255 to 4527 1 to 272       272/275
(98 %)
5 diff
(98.2 %id)
BU619886 Cell Line, Chondrosarcoma .a 4259 to 4687 447 to 19   AAA   429/429
(100 %)
0 diff
(100 %id)
BU622656 cell lines, Chondrosarcoma .a 4259 to 4687 447 to 19   AAA   429/429
(100 %)
0 diff
(100 %id)
CA446426 Chondrosarcoma, Left Pubic Bone .a 4260 to 4681 440 to 19   AAA   422/422
(100 %)
0 diff
(100 %id)
AI598122 adenocarcinoma, Pancreas .a 4262 to 4687 426 to 1       426/426
(100 %)
0 diff
(100 %id)
AA313079 Pancreas .a 4263 to 4522 8 to 267       260/267
(97 %)
6 diff
(97.8 %id)
BG110981 Bone, osteosarcoma, cell line .a 4263 to 5040 1 to 772       772/981
(78 %)
32 diff
(96.8 %id)
BG168084 hypernephroma, cell line, Kidney .a 4263 to 5068 1 to 802       802/933
(85 %)
16 diff
(98.3 %id)
CB150264 Liver .a 4263 to 4609 1 to 347       347/347
(100 %)
2 diff
(99.5 %id)
AA687639 normal prostate, Prostate .a 4264 to 4687 442 to 19   AAA   424/424
(100 %)
3 diff
(99.3 %id)
CK904065 Islets of Langerhans, Pancreas .a 4264 to 4717 1 to 454       454/454
(100 %)
0 diff
(100 %id)
BE349088 malignant melanoma, metastatic to lymphnode, skin .a 4265 to 4681 418 to 1       418/418
(100 %)
1 diff
(99.8 %id)
CN333190 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 4269 to 4808 1 to 540       540/544
(99 %)
2 diff
(99.7 %id)
W58051 heart .a 4269 to 4776 1 to 509       509/509
(100 %)
9 diff
(98.3 %id)
CN333185 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 4273 to 4523 1 to 252       252/252
(100 %)
3 diff
(98.9 %id)
Z24869 leg muscle, skeletal muscle .a 4274 to 4614 1 to 343       343/343
(100 %)
3 diff
(99.2 %id)
BU071707 insulinoma, Pancreas .a 4278 to 4779 3 to 504   fully sequenced,   502/504
(99 %)
5 diff
(99.1 %id)
BI963020 Islets of Langerhans, Pancreas .a 4280 to 4728 1 to 450       450/450
(100 %)
3 diff
(99.4 %id)
BI966208 Islets of Langerhans, Pancreas .a 4280 to 4772 1 to 493       493/493
(100 %)
0 diff
(100 %id)
TI_159701309   .a 4283 to 4920 778 to 141   AAA Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) 638/1025
(62 %)
27 diff
(97.4 %id)
AA382368 testis .a 4284 to 4453 49 to 218       170/218
(77 %)
6 diff
(97.3 %id)
AW953908   .a 4284 to 4844 48 to 604       557/604
(92 %)
6 diff
(99.1 %id)
BE890205 leiomyosarcoma, uterus .a 4285 to 4877 1 to 600       600/843
(71 %)
14 diff
(98.4 %id)
CB163093 Liver .a 4287 to 4852 1 to 566       566/566
(100 %)
2 diff
(99.7 %id)
BE814377 breast_normal .a 4289 to 4426 138 to 1       138/139
(99 %)
4 diff
(97.2 %id)
AA029669 heart .a 4304 to 4871 1 to 570       570/570
(100 %)
8 diff
(98.6 %id)
BG527192 lung, mucoepidermoid carcinoma .a 4307 to 5055 1 to 759       759/847
(89 %)
35 diff
(95.9 %id)
BG741391 skin .a 4312 to 5062 1 to 751       751/751
(100 %)
1 diff
(99.9 %id)
W19718 parathyroid gland, parathyroid tumor .a 4314 to 4723 1 to 415       415/415
(100 %)
16 diff
(96.2 %id)
AA346756 heart .a 4321 to 4621 1 to 301       301/301
(100 %)
1 diff
(99.7 %id)
AW376275 colon .a 4329 to 4488 163 to 5       159/163
(97 %)
0 diff
(100 %id)
AA724976 parathyroid gland, parathyroid tumor .a 4330 to 4688 363 to 5       359/363
(98 %)
0 diff
(100 %id)
AI033663 parathyroid gland, parathyroid tumor .a 4330 to 4692 366 to 4       363/366
(99 %)
0 diff
(100 %id)
BG743577 skin .a 4334 to 5123 1 to 795       795/796
(99 %)
9 diff
(98.9 %id)
CN333194 embryonic stem cells, DMSO-treated H9 cellline .a 4338 to 4541 1 to 204       204/204
(100 %)
1 diff
(99.6 %id)
AW351755 colon .a 4341 to 4892 1 to 551       551/569
(96 %)
11 diff
(98.1 %id)
BF914080 uterus_tumor .a 4346 to 4534 18 to 203       186/203
(91 %)
6 diff
(97.1 %id)
CN333191 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 4348 to 4700 1 to 353       353/353
(100 %)
1 diff
(99.8 %id)
BF915600 uterus_tumor .a 4356 to 4900 9 to 552       544/552
(98 %)
6 diff
(99.0 %id)
CN333196 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 4356 to 4526 1 to 171       171/171
(100 %)
3 diff
(98.3 %id)
DB330832 skeletal muscle .a 4358 to 4687 330 to 1       330/500
(66 %)
0 diff
(100 %id)
BF915493 uterus_tumor .a 4367 to 4936 14 to 584       571/585
(97 %)
24 diff
(95.9 %id)
BF574532 muscle (skeletal) .a 4370 to 5083 1 to 704       704/797
(88 %)
40 diff
(95.0 %id)
AI520834 adenocarcinoma, Pancreas .a 4373 to 4681 309 to 1       309/309
(100 %)
2 diff
(99.4 %id)
BF671644 muscle (skeletal) .a 4377 to 5092 1 to 717       717/1010
(70 %)
28 diff
(97.3 %id)
BI087733 cervix .a 4378 to 5185 1 to 809       809/810
(99 %)
11 diff
(98.7 %id)
TI_149300509   .a 4382 to 5360 1048 to 82   AAA   967/994
(97 %)
21 diff
(97.9 %id)
BG572515 placenta .a 4384 to 5085 1 to 702       702/702
(100 %)
8 diff
(98.9 %id)
N41772 placenta .a 4397 to 4849 1 to 465   fully sequenced,   465/465
(100 %)
9 diff
(98.1 %id)
BG678222 skin, squamous cell carcinoma .a 4402 to 5235 1 to 835       835/835
(100 %)
12 diff
(98.6 %id)
N79003 parathyroid gland, parathyroid tumor .a 4411 to 4688 279 to 2       278/287
(96 %)
0 diff
(100 %id)
CV570430 cornea, eye .a 4416 to 5001 1 to 585       585/585
(100 %)
2 diff
(99.7 %id)
BG565877 Liver .a 4438 to 5210 1 to 763       763/828
(92 %)
12 diff
(98.6 %id)
AW058495 Kidney .a 4454 to 4681 228 to 1       228/228
(100 %)
0 diff
(100 %id)
C20993   .a 4465 to 4687 1 to 223       223/223
(100 %)
0 diff
(100 %id)
AA430595   .a 4468 to 4964 1 to 497       497/497
(100 %)
1 diff
(99.8 %id)
AA430747   .a 4468 to 4897 1 to 430       430/430
(100 %)
1 diff
(99.8 %id)
AA434544   .a 4468 to 4957 1 to 490       490/490
(100 %)
1 diff
(99.8 %id)
BG570464 lung .a 4478 to 5173 26 to 718       693/720
(96 %)
15 diff
(98.0 %id)
N41777 placenta .a 4483 to 4824 1 to 349       349/379
(92 %)
12 diff
(96.9 %id)
CN333200 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 4486 to 4992 1 to 509       509/509
(100 %)
7 diff
(98.7 %id)
BX412481 placenta .a 4486 to 5358 877 to 1       877/877
(100 %)
7 diff
(99.3 %id)
BE777546 bone marrow, from chronic myelogenous leukemia .a 4492 to 5192 1 to 715       715/725
(98 %)
33 diff
(95.5 %id)
BG751537 eye, normal pigmented retinal epithelium .a 4507 to 5322 1 to 814       814/814
(100 %)
7 diff
(99.2 %id)
CV378940 head_neck .a 4520 to 4971 1 to 456       456/459
(99 %)
34 diff
(92.6 %id)
CN333197 embryonic stem cells, DMSO-treated H9 cellline .a 4547 to 5035 1 to 489       489/489
(100 %)
3 diff
(99.4 %id)
AA460878   .a 4552 to 4836 1 to 285       285/285
(100 %)
3 diff
(99.0 %id)
AA430596.
matches multiple genes
  .a 4555 to 4770 1 to 216     also hits gene RPL10andSNORA70 216/216
(100 %)
0 diff
(100 %id)
BM976563 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 4574 to 5360 804 to 19   AAA   786/786
(100 %)
4 diff
(99.5 %id)
BG290186 bladder, transitional cell papilloma, cell line .a 4576 to 5325 1 to 742       742/746
(99 %)
12 diff
(98.4 %id)
BQ893187 dorsal root ganglia .a 4576 to 5367 1 to 795       795/977
(81 %)
15 diff
(98.5 %id)
AL048399 uterus .a 4594 to 5363 795 to 24       772/797
(96 %)
0 diff
(100 %id)
TI_154101290   .a 4629 to 5366 812 to 84   AAA   729/766
(95 %)
15 diff
(98.1 %id)
TI_149291222   .a 4650 to 5360 789 to 82   AAA   708/711
(99 %)
5 diff
(99.3 %id)
BU607756 Human Lung Epithelial cells, lung .a 4660 to 5360 720 to 19   AAA   702/702
(100 %)
3 diff
(99.6 %id)
BU682055 lung .a 4670 to 5360 707 to 19   tiling clone, AAA   689/690
(99 %)
4 diff
(99.5 %id)
BU073244 insulinoma, Pancreas .a 4749 to 5368 638 to 19   tiling clone, fully sequenced, AAA   620/620
(100 %)
0 diff
(100 %id)
AU144754 whole embryo, mainly head .a 4793 to 5368 575 to 1       575/575
(100 %)
15 diff
(97.4 %id)
AU157869 placenta .a 4804 to 5368 558 to 1       558/558
(100 %)
19 diff
(96.6 %id)
N32771 placenta .a 4819 to 5360 553 to 1   fully sequenced,   553/553
(100 %)
22 diff
(96.1 %id)
AA460703   .a 4870 to 5360 509 to 19   AAA   491/491
(100 %)
0 diff
(100 %id)
AA181566   .a 4904 to 5345 442 to 1       442/443
(99 %)
0 diff
(100 %id)
BI966828 Islets of Langerhans, Pancreas .a 4906 to 5363 465 to 7       459/465
(98 %)
0 diff
(100 %id)
N20209 melanocyte .a 4941 to 5368 429 to 1       429/429
(100 %)
1 diff
(99.8 %id)
N92380 lung .a 4941 to 5272 338 to 6       333/338
(98 %)
0 diff
(100 %id)
AA186832   .a 5066 to 5360 321 to 27   AAA   295/295
(100 %)
1 diff
(99.7 %id)
N89975 parathyroid gland, parathyroid tumor .a 5185 to 5367 202 to 20   AAA   183/183
(100 %)
1 diff
(99.5 %id)
AY316529   .b 1 to 1490 1 to 1490 exact tiling clone,   1490/1490
(100 %)
0 diff
(100 %id)
NM_006106.3   .c 1 to 5218 1 to 5218 exact RefSeq, AAA   5218/5218
(100 %)
0 diff
(100 %id)
CN269041 embryonic stem cells, DMSO-treated H9 cellline .d 1 to 195 9 to 203   tiling clone,   195/203
(96 %)
6 diff
(97.1 %id)
AA159356 Pancreas .d 1 to 204 1 to 204   tiling clone, Submitted on the opposite strand 204/204
(100 %)
4 diff
(98.1 %id)
CX872390 embryonic stem .d 1 to 631 33 to 663   tiling clone,   631/663
(95 %)
11 diff
(98.4 %id)
CN280952 embryonic stem cells, cell lines H1, H7, andH9 .d 610 to 968 1 to 359       359/359
(100 %)
2 diff
(99.5 %id)
CB994840 placenta, pre-eclamptic placenta .d 624 to 1130 28 to 541   tiling clone,   514/935
(54 %)
34 diff
(96.4 %id)
BM921296 pooled brain, lung, testis .d 630 to 1012 1 to 384       384/1306
(29 %)
12 diff
(99.1 %id)
CR618214 fetal brain .d 635 to 3027 1 to 2393 exact tiling clone,   2393/2393
(100 %)
0 diff
(100 %id)
AL536674 brain, fetal brain .d 635 to 1585 1 to 942       942/942
(100 %)
19 diff
(98.0 %id)
BU859151 ovary, teratocarcinoma, cell line .d 639 to 1422 1 to 792       792/1009
(78 %)
29 diff
(97.2 %id)
BQ433382 melanotic melanoma, skin .d 652 to 1344 1 to 697       697/950
(73 %)
18 diff
(98.2 %id)
CX780993 human embryonic stem cells .d 653 to 1437 1 to 785       785/785
(100 %)
0 diff
(100 %id)
BM918433 pooled pancreas and spleen .d 731 to 1344 1 to 616       616/1193
(51 %)
18 diff
(98.5 %id)
ES311693 frontal balding hair, skin .d 885 to 1041 1 to 153       153/161
(95 %)
10 diff
(93.8 %id)
CN401255 embryonic stem cells, cell lines H1, H7, andH9 .d 938 to 1213 276 to 1     Submitted on the opposite strand 276/276
(100 %)
0 diff
(100 %id)
CN401259 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 964 to 1318 356 to 2     Submitted on the opposite strand 355/356
(99 %)
0 diff
(100 %id)
EC497821 Prostate .d 1233 to 1344 1 to 112       112/114
(98 %)
3 diff
(97.4 %id)
BX433233 brain, fetal brain .d 1352 to 2244 889 to 1       889/889
(100 %)
5 diff
(99.5 %id)
BX452269 brain, fetal brain .d 1401 to 2279 1 to 888       888/902
(98 %)
24 diff
(97.4 %id)
BI223791 cervical carcinoma cell line, cervix .d 1744 to 2593 1 to 847       847/849
(99 %)
15 diff
(98.3 %id)
CX780929 human embryonic stem cells .d 2419 to 3056 663 to 26   tiling clone, AAA   638/638
(100 %)
5 diff
(99.3 %id)
AL832620 human spinal cord .e 1 to 4671 1 to 4672 exact tiling clone, available from DKFZ, AAA   4672/4672
(100 %)
4 diff
(100.0 %id)
BF095979 uterus_tumor .e 362 to 483 22 to 144       123/144
(85 %)
6 diff
(95.9 %id)
BU629026 cell lines, Chondrosarcoma .e 3993 to 4671 696 to 19   AAA   678/678
(100 %)
5 diff
(99.3 %id)
BU634374 cell lines, Chondrosarcoma .e 3994 to 4679 703 to 19   AAA   685/686
(99 %)
2 diff
(99.8 %id)
BF093962 uterus_tumor .e 4001 to 4312 313 to 3       311/318
(97 %)
0 diff
(100 %id)
BG403042 bladder, transitional cell papilloma, cell line .e 4034 to 4600 1 to 566   AAA   566/585
(96 %)
3 diff
(99.5 %id)
H45126 breast .e 4042 to 4458 1 to 426   fully sequenced,   426/426
(100 %)
10 diff
(97.7 %id)
CA441791 Chondrosarcoma, Left Pubic Bone .e 4051 to 4677 645 to 19   AAA   627/627
(100 %)
1 diff
(99.9 %id)
BF083745 colon .e 4054 to 4272 220 to 3       218/226
(96 %)
0 diff
(100 %id)
AI357665 ovary, tumor, 5 pooled (see description) .e 4078 to 4468 8 to 398     Submitted on the opposite strand 391/398
(98 %)
6 diff
(98.5 %id)
TI_149305376   .e 4082 to 4671 723 to 133   AAA   591/906
(65 %)
10 diff
(98.9 %id)
D11550 Liver .e 4084 to 4590 1 to 515       515/592
(86 %)
23 diff
(96.2 %id)
D12325 Liver .e 4084 to 4599 1 to 521     Submitted on the opposite strand 521/590
(88 %)
8 diff
(98.7 %id)
TI_149284544   .e 4088 to 4671 703 to 120   AAA   584/1088
(53 %)
16 diff
(98.6 %id)
CB046778.
matches multiple genes
2 pooled tumors (clear cell type), Kidney .e 4092 to 4671 618 to 39   AAA Suspected internal deletion, also hits gene smujer 580/589
(98 %)
1 diff
(99.9 %id)
BG927585 cartilage .e 4114 to 4649 88 to 623       536/553
(96 %)
7 diff
(98.8 %id)
CK904064 Islets of Langerhans, Pancreas .e 4114 to 4674 567 to 7       561/567
(98 %)
0 diff
(100 %id)
BM994147 lung, Metastatic Chondrosarcoma .e 4121 to 4672 570 to 19   AAA   552/552
(100 %)
2 diff
(99.7 %id)
BM922032 pooled brain, lung, testis .e 4122 to 4677 13 to 568       556/1078
(51 %)
3 diff
(99.8 %id)
BM921473 pooled brain, lung, testis .e 4125 to 4678 13 to 562       550/1088
(50 %)
7 diff
(99.4 %id)
AW265576 normal squamous epithelium, floor of mouth .e 4131 to 4602 1 to 472     Submitted on the opposite strand 472/494
(95 %)
6 diff
(98.8 %id)
BI480948 Native Retinal Pigment Epithelium sheets, retina .e 4139 to 4675 12 to 551       540/556
(97 %)
4 diff
(99.3 %id)
BF247906 hypernephroma, Kidney .e 4139 to 4671 1 to 527   AAA   527/527
(100 %)
16 diff
(97.0 %id)
DV460003 cochlea, ear .e 4139 to 4357 224 to 6     Submitted on the opposite strand 219/224
(97 %)
0 diff
(100 %id)
T27864 lung .e 4140 to 4312 1 to 173       173/173
(100 %)
1 diff
(99.5 %id)
AW340402 pooled .e 4144 to 4674 538 to 7       532/538
(98 %)
0 diff
(100 %id)
BF446041 breast, invasive ductal carcinoma, 3 pooled samples .e 4145 to 4679 540 to 6       535/540
(99 %)
0 diff
(100 %id)
AW950051   .e 4147 to 4671 1 to 525   AAA   525/525
(100 %)
0 diff
(100 %id)
AW451272   .e 4147 to 4671 544 to 18   AAA   527/527
(100 %)
1 diff
(99.9 %id)
AI432351 pooled .e 4158 to 4674 520 to 4       517/520
(99 %)
0 diff
(100 %id)
AW071473 connective tissue, five pooled sarcomas, including myxoidliposarcoma, solitary fibrous tumor, malignant fibroushistiocytoma, gastrointestinal stromal tumor, andmesothelioma .e 4158 to 4671 514 to 1       514/514
(100 %)
1 diff
(99.9 %id)
T49110 placenta .e 4163 to 4410 1 to 251   fully sequenced,   251/251
(100 %)
1 diff
(99.7 %id)
AI394425 pooled .e 4167 to 4674 511 to 4       508/511
(99 %)
0 diff
(100 %id)
AI005171 pooled .e 4173 to 4670 498 to 1       498/498
(100 %)
0 diff
(100 %id)
D53788   .e 4187 to 4519 1 to 333       333/333
(100 %)
0 diff
(100 %id)
D53830   .e 4187 to 4444 1 to 258       258/258
(100 %)
1 diff
(99.7 %id)
AI889397 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .e 4213 to 4671 476 to 18   AAA   459/459
(100 %)
2 diff
(99.6 %id)
AW117488 pooled .e 4213 to 4674 466 to 4       463/466
(99 %)
0 diff
(100 %id)
AI831200 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .e 4214 to 4674 461 to 1       461/461
(100 %)
0 diff
(100 %id)
BE042859 colon, moderately-differentiated adenocarcinoma .e 4214 to 4677 465 to 2       464/465
(99 %)
0 diff
(100 %id)
AI340078   .e 4215 to 4674 461 to 2       460/461
(99 %)
0 diff
(100 %id)
AI491905 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .e 4215 to 4671 470 to 13   AAA   458/458
(100 %)
1 diff
(99.8 %id)
AW104384 pooled .e 4215 to 4670 456 to 1       456/456
(100 %)
1 diff
(99.8 %id)
AW612907 colon, moderately-differentiated adenocarcinoma .e 4215 to 4671 457 to 1       457/457
(100 %)
0 diff
(100 %id)
AW194099 serous papillary carcinoma, high grade, 2pooled tumors, uterus .e 4216 to 4671 467 to 12   AAA   456/456
(100 %)
3 diff
(99.4 %id)
BE940303 uterus_tumor .e 4218 to 4494 21 to 292       272/292
(93 %)
6 diff
(98.0 %id)
BE940307 uterus_tumor .e 4218 to 4460 10 to 257       248/257
(96 %)
6 diff
(97.7 %id)
BU685736 lung, Primary Lung Epithelial Cells .e 4222 to 4671 468 to 19   AAA   450/450
(100 %)
3 diff
(99.4 %id)
AA781002 parathyroid gland, parathyroid tumor .e 4223 to 4679 465 to 9       457/465
(98 %)
0 diff
(100 %id)
DB528265 hippocampus .e 4225 to 4671 1 to 446     Submitted on the opposite strand 446/446
(100 %)
7 diff
(98.5 %id)
AI827322 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .e 4225 to 4674 450 to 1       450/450
(100 %)
0 diff
(100 %id)
EH353196   .e 4226 to 4288 1 to 63       63/65
(96 %)
1 diff
(98.5 %id)
AW265465 normal squamous epithelium, floor of mouth .e 4226 to 4602 1 to 377     Submitted on the opposite strand 377/434
(86 %)
3 diff
(99.4 %id)
BE940299 uterus_tumor .e 4227 to 4526 1 to 300       300/300
(100 %)
1 diff
(99.7 %id)
BF909790 uterus_tumor .e 4227 to 4611 1 to 385       385/394
(97 %)
20 diff
(95.0 %id)
AA779849   .e 4231 to 4672 442 to 1       442/442
(100 %)
6 diff
(98.7 %id)
AI277256 placenta .e 4232 to 4679 453 to 6       448/453
(98 %)
0 diff
(100 %id)
AI628671 Kidney .e 4232 to 4671 461 to 22   AAA   440/440
(100 %)
2 diff
(99.6 %id)
CD242078 Blood vessels - aorta, basilar and artery .e 4239 to 4674 1 to 436       436/470
(92 %)
3 diff
(99.4 %id)
BF540855 hypernephroma, Kidney .e 4241 to 4674 1 to 433       433/786
(55 %)
3 diff
(99.7 %id)
AI373930 uterus .e 4243 to 4671 449 to 21   AAA   429/429
(100 %)
3 diff
(99.4 %id)
AA550727 normal prostatic epithelial cells, Prostate .e 4245 to 4674 436 to 6       431/436
(98 %)
0 diff
(100 %id)
BI966028 Islets of Langerhans, Pancreas .e 4250 to 4674 432 to 7       426/432
(98 %)
0 diff
(100 %id)
AI208069   .e 4251 to 4674 425 to 2       424/425
(99 %)
0 diff
(100 %id)
W58374.
matches multiple genes
heart .e 4254 to 4671 437 to 17   AAA also hits gene papa 421/421
(100 %)
3 diff
(99.3 %id)
AI963820 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .e 4260 to 4671 412 to 1       412/412
(100 %)
0 diff
(100 %id)
AA610311 breast .e 4264 to 4671 408 to 1       408/408
(100 %)
0 diff
(100 %id)
AA992459 carcinoid, lung .e 4266 to 4678 413 to 1       413/413
(100 %)
0 diff
(100 %id)
EC584380 Prostate .e 4274 to 4373 1 to 97       97/97
(100 %)
3 diff
(97.0 %id)
AI015834   .e 4274 to 4674 401 to 1       401/401
(100 %)
0 diff
(100 %id)
AA973159 pooled .e 4275 to 4672 398 to 1       398/398
(100 %)
0 diff
(100 %id)
BG121585 adenocarcinoma, cell line, Liver .e 4281 to 4671 1 to 386   AAA   386/386
(100 %)
5 diff
(98.8 %id)
H88456 cochlea, ear .e 4282 to 4608 1 to 327       327/327
(100 %)
2 diff
(99.4 %id)
CD677928 eye, Trabecular meshwork .e 4286 to 4746 1 to 461       461/461
(100 %)
6 diff
(98.7 %id)
H88387.
matches multiple genes
cochlea, ear .e 4299 to 4654 367 to 1     also hits gene FNDC1 367/369
(99 %)
13 diff
(96.5 %id)
AI128142 uterus .e 4303 to 4679 387 to 11   AAA   377/377
(100 %)
0 diff
(100 %id)
BF915442 uterus_tumor .e 4308 to 4561 259 to 4     Submitted on the opposite strand 256/259
(98 %)
0 diff
(100 %id)
AI186383 heart .e 4308 to 4671 364 to 1       364/365
(99 %)
0 diff
(100 %id)
AA872173 pooled germ cell tumors .e 4317 to 4670 354 to 1       354/354
(100 %)
0 diff
(100 %id)
AA642545 normal prostate, Prostate .e 4327 to 4678 357 to 5       353/357
(98 %)
0 diff
(100 %id)
AI272990 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .e 4329 to 4679 352 to 1       352/352
(100 %)
1 diff
(99.8 %id)
AI184829 heart .e 4338 to 4671 334 to 1       334/334
(100 %)
0 diff
(100 %id)
AW083790 colon, moderately differentiated adenocarcinoma .e 4361 to 4673 313 to 1       313/335
(93 %)
0 diff
(100 %id)
AI474170 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 4362 to 4679 318 to 1       318/318
(100 %)
0 diff
(100 %id)
BF914511 uterus_tumor .e 4364 to 4565 203 to 1     Submitted on the opposite strand 203/203
(100 %)
5 diff
(97.6 %id)
AI561312 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .e 4367 to 4671 305 to 1       305/305
(100 %)
0 diff
(100 %id)
BU940597 mixed (pool of 40 RNAs) .e 4370 to 4679 1 to 310       310/374
(82 %)
1 diff
(99.8 %id)
BU941734 mixed (pool of 40 RNAs) .e 4370 to 4679 1 to 310       310/877
(35 %)
1 diff
(99.9 %id)
CV393547 ovary .e 4377 to 4575 203 to 7     Submitted on the opposite strand 197/203
(97 %)
0 diff
(100 %id)
T49111 placenta .e 4380 to 4671 308 to 1   fully sequenced,   308/308
(100 %)
2 diff
(99.4 %id)
H45429 breast .e 4428 to 4671 257 to 10   fully sequenced,   248/257
(96 %)
6 diff
(97.7 %id)
EC493087 Prostate .e 4495 to 4601 1 to 104       104/104
(100 %)
5 diff
(95.2 %id)
BE047732 brain, tumor, 5 pooled (see description) .e 4496 to 4679 1 to 184       184/267
(68 %)
1 diff
(99.7 %id)
AA917078 pooled .e 4507 to 4801 295 to 1   tiling clone,   295/295
(100 %)
0 diff
(100 %id)
AA887603 Kidney .e 4513 to 4676 164 to 1       164/164
(100 %)
0 diff
(100 %id)
CN290799.
matches multiple genes
embryonic stem cells, DMSO-treated H9 cellline .e 4556 to 4678 133 to 10     Submitted on the opposite strand, also hits gene smujer 124/133
(93 %)
0 diff
(100 %id)
N33982 melanocyte .f 1 to 466 1 to 466   tiling clone,   466/467
(99 %)
4 diff
(99.2 %id)
N44093 melanocyte .f 3 to 279 1 to 279   tiling clone,   279/279
(100 %)
5 diff
(98.3 %id)
N33890 melanocyte .f 6 to 322 1 to 317       317/339
(93 %)
3 diff
(99.2 %id)
AK304485 uterus .f 502 to 1916 1 to 1415   tiling clone,   1415/1415
(100 %)
1 diff
(100.0 %id)
DC419625 uterus .f 502 to 1071 1 to 570       570/570
(100 %)
1 diff
(99.9 %id)
W00377 melanocyte .f 691 to 1045 1 to 361   tiling clone,   361/364
(99 %)
14 diff
(96.2 %id)
N36089 melanocyte .f 1456 to 1958 503 to 1   tiling clone,   503/503
(100 %)
1 diff
(99.9 %id)
N24539 melanocyte .f 1483 to 1736 253 to 1       253/254
(99 %)
2 diff
(99.3 %id)
N25254 melanocyte .f 1523 to 1958 441 to 1       441/463
(95 %)
5 diff
(99.0 %id)
DW441409 Liver .g 1 to 212 227 to 16   tiling clone,   212/238
(89 %)
0 diff
(100 %id)
AA854862 parathyroid gland, parathyroid tumor .g 31 to 458 8 to 434     Submitted on the opposite strand 427/427
(100 %)
1 diff
(99.8 %id)
AI033608 parathyroid gland, parathyroid tumor .g 31 to 524 8 to 501   tiling clone, Submitted on the opposite strand 494/494
(100 %)
3 diff
(99.4 %id)
AK316116 thalamus .g 98 to 1735 1 to 1638 M192I tiling clone,   1638/1638
(100 %)
3 diff
(99.9 %id)
DC344064 thalamus .g 98 to 655 1 to 558       558/558
(100 %)
1 diff
(99.9 %id)
W19965 parathyroid gland, parathyroid tumor .g 113 to 521 411 to 1     Submitted on the opposite strand 411/434
(94 %)
9 diff
(98.0 %id)
BX112895 melanocyte .g 258 to 975 1 to 720       720/720
(100 %)
2 diff
(99.8 %id)
BI755517 brain .h 1 to 772 1 to 829   tiling clone,   829/1032
(80 %)
57 diff
(94.5 %id)
TI_57218827   .h 1 to 772 59 to 887       829/1090
(76 %)
55 diff
(95.0 %id)
BG202124   .h 660 to 1432 1 to 770   tiling clone,   770/780
(98 %)
8 diff
(99.0 %id)
AW273978 invasive adenocarcinoma, lung .h 1260 to 1412 155 to 3   tiling clone,   153/155
(98 %)
0 diff
(100 %id)
CB128203 Liver .i 1 to 523 1 to 522 H5T S6H S7H R9G L10W ... tiling clone,   522/522
(100 %)
2 diff
(99.7 %id)
BX470756   .j-u 1 to 698 1 to 698 exact tiling clone,   698/698
(100 %)
2 diff
(99.8 %id)
DB132178 thymus .k 1 to 576 2 to 577 exact tiling clone, capped   576/576
(100 %)
0 diff
(100 %id)
BU838359 dorsal root ganglia .l-u 1 to 948 1 to 955 exact tiling clone,   955/958
(99 %)
16 diff
(98.4 %id)
DB262645 uterus .l-u 941 to 1521 2 to 583   tiling clone, capped   582/582
(100 %)
3 diff
(99.5 %id)
AI474898 Kidney .l-u 955 to 1111 1 to 158     Submitted on the opposite strand 158/158
(100 %)
1 diff
(99.4 %id)
BI480647 Native Retinal Pigment Epithelium sheets, retina .l-u 1076 to 1485 5 to 415   tiling clone,   411/416
(98 %)
9 diff
(97.9 %id)
CR736520 Kidney .l-u 1141 to 1618 478 to 1   tiling clone, Submitted on the opposite strand 478/478
(100 %)
0 diff
(100 %id)
BX508789   .l-u 1274 to 1893 1 to 620   tiling clone,   620/620
(100 %)
1 diff
(99.9 %id)
CV340162 colon_ins .l-u 1607 to 1948 1 to 338   tiling clone,   338/338
(100 %)
8 diff
(97.7 %id)
FN085991 breast carcinoma .m-u 1 to 77 79 to 1   tiling clone, Submitted on the opposite strand 79/80
(98 %)
1 diff
(98.8 %id)
AA478883.
matches multiple genes
mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .m-u 3 to 495 1 to 493 exact tiling clone, also hits gene ADCK4 493/493
(100 %)
1 diff
(99.8 %id)
BE504889 pooled germ cell tumors .m-u 84 to 648 565 to 1   tiling clone,   565/565
(100 %)
0 diff
(100 %id)
AA846382   .m-u 193 to 651 459 to 1   tiling clone,   459/459
(100 %)
1 diff
(99.8 %id)
AW873266 normal epithelium, thyroid .m-u 289 to 610 9 to 330     Submitted on the opposite strand 322/330
(97 %)
6 diff
(98.2 %id)
AI699330 pooled .n-u 1 to 360 362 to 4 exact tiling clone,   359/362
(99 %)
0 diff
(100 %id)
BF381021 uterus_tumor .o-u 1 to 296 10 to 304 exact tiling clone,   295/304
(97 %)
6 diff
(98.1 %id)
BF381023 uterus_tumor .o-u 3 to 296 1 to 293 exact     293/293
(100 %)
9 diff
(97.0 %id)
CV414504 uterus_tumor .o-u 3 to 182 1 to 181 L9F Q10T K11R L12N G13R ...     181/181
(100 %)
11 diff
(94.0 %id)
BF336326 colon .o-u 4 to 296 1 to 292 F23Y     292/292
(100 %)
6 diff
(98.0 %id)
BF381019 uterus_tumor .o-u 8 to 296 1 to 284 L12R G13D H14M G15V D16M ...     284/284
(100 %)
10 diff
(96.5 %id)
BF381005 uterus_tumor .o-u 9 to 297 1 to 289 L9V     289/290
(99 %)
4 diff
(98.7 %id)
BF381016 uterus_tumor .o-u 10 to 296 1 to 285 L9V C19G     285/285
(100 %)
7 diff
(97.6 %id)
CV414476 uterus_tumor .o-u 10 to 296 1 to 285 L9V L12R C19G     285/285
(100 %)
17 diff
(94.1 %id)
BF336324 colon .o-u 20 to 308 296 to 8 exact     289/296
(97 %)
6 diff
(98.0 %id)
BF380991 uterus_tumor .o-u 20 to 252 263 to 31 K11*     233/263
(88 %)
0 diff
(100 %id)
BF381004 uterus_tumor .o-u 20 to 298 292 to 14 exact     279/292
(95 %)
0 diff
(100 %id)
BF381026 uterus_tumor .o-u 20 to 307 292 to 5 exact     288/292
(98 %)
0 diff
(100 %id)
BF381031 uterus_tumor .o-u 20 to 265 247 to 1 L9F Y18I C19V L20S S21P ...     247/247
(100 %)
16 diff
(93.6 %id)
BF381035 uterus_tumor .o-u 20 to 300 284 to 6 Y18I C19V L20S S21P S22V ... tiling clone,   279/284
(98 %)
0 diff
(100 %id)
CV414490 uterus_tumor .o-u 20 to 279 263 to 4 L12P   Submitted on the opposite strand 260/263
(98 %)
0 diff
(100 %id)
CV414509 uterus_tumor .o-u 20 to 287 271 to 2 L9F Y18I C19V L20S S21P ...   Submitted on the opposite strand 270/271
(99 %)
0 diff
(100 %id)
BF380988 uterus_tumor .o-u 26 to 296 1 to 273 exact     273/273
(100 %)
6 diff
(97.9 %id)
CV310320 colon .o-u 41 to 296 1 to 261 W2C K3G I4K V5S I6V ...     261/261
(100 %)
17 diff
(93.5 %id)
BF381008 uterus_tumor .o-u 47 to 296 1 to 248 L9V C19G     248/248
(100 %)
11 diff
(95.6 %id)
BF381012 uterus_tumor .o-u 48 to 296 1 to 248 L9V C19S F23I     248/248
(100 %)
12 diff
(95.2 %id)
BF381007 uterus_tumor .o-u 52 to 296 13 to 255 L9Y Q10R K11N L12G G13T ...     243/255
(95 %)
6 diff
(97.7 %id)
BF381006 uterus_tumor .o-u 114 to 296 1 to 183   tiling clone,   183/183
(100 %)
5 diff
(97.3 %id)
CV414486 uterus_tumor .o-u 167 to 292 126 to 4     Submitted on the opposite strand 123/126
(97 %)
0 diff
(100 %id)
AV703983 adrenal gland Gene YAP1, variant not shown         Suspected internal deletion, this clone was ignored    
AK300414 placenta Gene YAP1, variant not shown         Suspected internal deletion, this clone was ignored    
AK310620 thymus Gene YAP1, variant not shown         Suspected internal deletion, this clone was ignored    
BE815085 breast_normal Gene YAP1, variant not shown              
DA397154 thalamus Gene YAP1, variant not shown       capped      
AL602531 human skeletal muscle Gene YAP1, variant not shown              
AV650494 corresponding non cancerous liver tissue Gene YAP1, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
AI493033 Kidney Gene YAP1, variant not shown         This clone was ignored    
AW088330 ovary, tumor, 5 pooled (see description) Gene YAP1, variant not shown              
AW275333 Kidney Gene YAP1, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
BF983999 duodenal adenocarcinoma, cell line, small intestine Gene YAP1, variant not shown              
BF983659 duodenal adenocarcinoma, cell line, small intestine Gene YAP1, variant not shown              
DC382349 placenta Gene YAP1, variant not shown         Suspected internal deletion, this clone was ignored    
DB230387 trachea Gene YAP1, variant not shown       capped      
DB349972 trachea Gene YAP1, variant not shown              
DB230407 trachea Gene YAP1, variant not shown       capped      
DB349975 trachea Gene YAP1, variant not shown              
BM683531 eye, fetal eye Gene YAP1, variant not shown       AAA Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base)    
BM718486 eye, fetal eye Gene YAP1, variant not shown         Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base)    
DB279805 uterus Gene YAP1, variant not shown       capped This clone was ignored    
DB352409 uterus Gene YAP1, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j-u, .k, .l-u, .m-u, .n-u, .o-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI